Ohio Public Employees Retirement System (OPERS)’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.26M Buy
32,250
+536
+2% +$17.3K ﹤0.01% 1254
2026
Q1
$1.03M Sell
31,714
-1,081
-3% -$34.7K ﹤0.01% 1306
2025
Q4
$1.15M Sell
32,795
-1,244
-4% -$44.1K ﹤0.01% 1307
2025
Q3
$895K Buy
34,039
+211
+0.6% +$6.29K ﹤0.01% 1372
2025
Q2
$896K Buy
33,828
+1,103
+3% +$29K ﹤0.01% 1369
2025
Q1
$790K Sell
32,725
-14,822
-31% -$468K ﹤0.01% 1382
2024
Q4
$1.91M Buy
47,547
+2,295
+5% +$131K 0.01% 1150
2024
Q3
$2.86M Buy
45,252
+5,155
+13% +$302K 0.01% 920
2024
Q2
$2.13M Buy
+40,097
New +$2.63M 0.01% 945
2023
Q3
Sell
-34,380
Closed -$557K 1994
2023
Q2
$557K Buy
34,380
+6,814
+25% +$143K ﹤0.01% 1261
2023
Q1
$459K Buy
+27,566
New +$285K ﹤0.01% 1282

Other funds holding VKTX

Ohio Public Employees Retirement System (OPERS)'s VKTX Position: Q2 2026 in Review

Ohio Public Employees Retirement System (OPERS) increased its Viking Therapeutics (VKTX) stake by 1.7% in Q2 2026, buying an estimated $17.3K and bringing the position to 32,250 shares worth $1.26M. The position accounts for ﹤0.01% of the portfolio, ranked #1254.

Ohio Public Employees Retirement System (OPERS) first reported a position in VKTX in Q1 2023 and has held it in 11 quarters since. The position peaked at $2.86M in Q3 2024. 432 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Ohio Public Employees Retirement System (OPERS) held 32,250 shares of Viking Therapeutics worth $1.26M as of Q2 2026.
  • Ohio Public Employees Retirement System (OPERS) bought 536 Viking Therapeutics shares in Q2 2026, an estimated $17.3K.
  • Viking Therapeutics made up ﹤0.01% of Ohio Public Employees Retirement System (OPERS)'s portfolio in Q2 2026, its #1254 holding.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Viking Therapeutics in Q1 2023 and has held it in 11 quarters since.
  • Ohio Public Employees Retirement System (OPERS)'s Viking Therapeutics position peaked at $2.86M in Q3 2024.
  • 432 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q2 2026, filed 17 Aug 2026.